TY - JOUR
T1 - T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia
T2 - A historical perspective and search for consensus
AU - Rashidi, Armin
AU - Fisher, Stephen I.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - There is a rich history behind the extinct entity 'T-cell chronic lymphocytic leukemia (T-CLL)' and the now-established replacement, small-cell variant of T-cell prolymphocytic leukemia (T-PLL-sv). Herein, we review the history of the events, observations, and discussions that led to this replacement. We also provide a systematic analysis of all previously reported cases of T-PLL-sv as well as our four new additional cases. Despite the higher frequency of a normal karyotype and perhaps an overrepresented CD4-CD8- immunophenotype among these patients (compared to T-PLL in general) as well as bland morphology (that makes them superficially appear more similar to B-CLL), we argue that the current World Health Organization (WHO)-based classification as T-PLL-sv is adequate and should continue for the time being. Morphologically, T-PLL-sv represents approximately one-fifth of all T-PLL cases. However, morphology alone does not determine the clinical course and should not be the basis for clinical decision making and prognostication. We propose a clonal evolution model in which mature T-cell leukemias classified in the past as T-CLL are perhaps T-PLL diagnosed early in the course of the disease. Future research using next-generation sequencing, comparative genomic hybridization, and molecular array studies, including serial analyses of individual cases over time, is needed to better identify this rarely diagnosed, inherently controversial form of T-cell leukemia.
AB - There is a rich history behind the extinct entity 'T-cell chronic lymphocytic leukemia (T-CLL)' and the now-established replacement, small-cell variant of T-cell prolymphocytic leukemia (T-PLL-sv). Herein, we review the history of the events, observations, and discussions that led to this replacement. We also provide a systematic analysis of all previously reported cases of T-PLL-sv as well as our four new additional cases. Despite the higher frequency of a normal karyotype and perhaps an overrepresented CD4-CD8- immunophenotype among these patients (compared to T-PLL in general) as well as bland morphology (that makes them superficially appear more similar to B-CLL), we argue that the current World Health Organization (WHO)-based classification as T-PLL-sv is adequate and should continue for the time being. Morphologically, T-PLL-sv represents approximately one-fifth of all T-PLL cases. However, morphology alone does not determine the clinical course and should not be the basis for clinical decision making and prognostication. We propose a clonal evolution model in which mature T-cell leukemias classified in the past as T-CLL are perhaps T-PLL diagnosed early in the course of the disease. Future research using next-generation sequencing, comparative genomic hybridization, and molecular array studies, including serial analyses of individual cases over time, is needed to better identify this rarely diagnosed, inherently controversial form of T-cell leukemia.
KW - Chronic lymphocytic leukemia
KW - Nucleolus
KW - Prolymphocytic leukemia
KW - Small-cell variant
KW - World Health Organization
UR - http://www.scopus.com/inward/record.url?scp=84938986372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938986372&partnerID=8YFLogxK
U2 - 10.1111/ejh.12560
DO - 10.1111/ejh.12560
M3 - Review article
C2 - 25846234
AN - SCOPUS:84938986372
SN - 0902-4441
VL - 95
SP - 199
EP - 210
JO - European Journal of Haematology
JF - European Journal of Haematology
IS - 3
ER -